Latest Taxation News

ANZ Group Holdings Limited has updated details for its 2026 Interim Dividend, confirming an 83-cent payment per share, partially franked, with dividend reinvestment and bonus option plans priced at AUD 35.31.

ParagonCare anticipates recovering up to 32.5% of its exposure to the insolvent Infinity Retail Pharmacy Group, while maintaining a steady FY26 earnings outlook amid cost pressures.

Whitefield Income Limited is raising up to A$108 million through a 2 for 5 entitlement offer priced at A$1.22 per share, aiming to boost its net asset value and expand its investor base.

Zimplats acknowledges Zimbabwe’s classification of platinum group metals as critical minerals and commits to working with the government to navigate the new policy framework while supporting local value addition.

The Australian Taxation Office has issued a Class Ruling confirming scrip for scrip capital gains tax roll-over relief for Diversified United Investment shareholders following their merger with Australian United Investment Company.

Strategic Elements Limited is raising up to $1 million via a Share Purchase Plan (SPP) at 3.5 cents per share, with attaching options exercisable at 4 cents, to fuel development in Energy Ink™ and Stealth Technologies.

Despite sweeping changes to Capital Gains Tax announced in the 2026/27 Federal Budget, Acrux Limited’s status as a Pooled Development Fund ensures its shareholders remain shielded from these new tax rules.

FireFly Metals has completed an in-specie distribution of 60 million Bellavista shares to eligible shareholders following the sale of its Ontario gold projects. Trading in Bellavista shares begins 12 May 2026, while FireFly awaits an ATO ruling on tax implications.

BlackRock Investment Management (Australia) Limited has confirmed cash distributions for four Australian iShares ETFs, with payments scheduled for mid-May and the Distribution Reinvestment Plan open for investors.

Andromeda Metals has secured a $1.66 million cash refund from the Australian Government's R&D Tax Incentive program, reflecting $3.4 million of eligible expenditure tied to its Great White Project.

The Smart US 500 ETF reported a near-billion-dollar fund size with a 5-year average annual return of 14.14% after fees and tax, maintaining a high-risk profile and low management fees of 0.34%.

Recce Pharmaceuticals bolsters its clinical and commercial pipeline with a $5.3 million AUD R&D tax rebate, a second U.S. Army research agreement for its RECCE 327 Gel, and a key patent granted in Brazil, while progressing Phase 3 trials in Indonesia.